Current Opinion in Rheumatology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.4 | Q1 | 89.7% | 1.572 | Q1 | 92.7% |
| 2024 | 4.3 | Q1 | 82.8% | 1.704 | Q1 | 93.8% |
| 2023 | 5.2 | Q1 | 89.5% | 1.467 | Q1 | 92.4% |
| 2022 | 5.1 | Q2 | 85.5% | 1.489 | Q1 | 92.9% |
| 2021 | 4.9 | Q2 | 75.0% | 1.446 | Q1 | 92.7% |
| 2020 | — | — | 1.452 | Q1 | 92.0% | |
| 2019 | — | — | 1.525 | Q1 | 92.8% | |
| 2018 | — | — | 1.742 | Q1 | 93.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1040-8711
ISSN
1531-6963
country
UScoverage
1989-2026